Healthcare


Genetic Technology Alert. Using Bimodal Genetic Biomarkers for Colon Cancer Prognosis; Nanoparticle Conjugates for Topical Delivery of siRNA; Cell-Based Model of Alzheimer's Disease Developed

Share this:

This issue profiles using bimodal genetic biomarkers for colon cancer prognosis, nanoparticle conjugates for topical delivery of siRNA, and development of a cell-based model of Alzheimer's disease

Click headings to expand and collapse Published: 20 Jul 2012

Tools

Features of this research

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..